Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Stock
Equities
600671
CNE000000BF3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.42 CNY | -0.82% | -4.10% | -27.79% |
Sales 2022 | 109M 15.07M | Sales 2023 | 122M 16.85M | Capitalization | 1.42B 197M |
---|---|---|---|---|---|
Net income 2022 | -67M -9.27M | Net income 2023 | -38M -5.26M | EV / Sales 2022 | 11.3 x |
Net Debt 2022 | 73.65M 10.19M | Net Debt 2023 | 16.8M 2.33M | EV / Sales 2023 | 11.8 x |
P/E ratio 2022 |
-17.3
x | P/E ratio 2023 |
-37.1
x | Employees | 371 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.72% |
1 day | -0.24% | ||
1 week | -3.30% | ||
Current month | -3.30% | ||
1 month | -11.75% | ||
3 months | -2.97% | ||
6 months | -20.28% | ||
Current year | -27.19% |
Managers | Title | Age | Since |
---|---|---|---|
Xu Yu Xu
CEO | Chief Executive Officer | 46 | 23-09-26 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hua Cheng
BRD | Director/Board Member | 55 | 91-12-31 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 8.42 | -0.82% | 384 599 |
24-05-07 | 8.49 | -0.24% | 269,455 |
24-05-06 | 8.51 | -3.08% | 479,469 |
24-04-30 | 8.78 | -0.11% | 326,000 |
End-of-day quote Shanghai S.E., May 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-27.19% | 143M | |
+33.43% | 700B | |
+27.75% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.28% | 236B | |
+6.67% | 202B | |
-8.92% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- 600671 Stock